These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 7621099

  • 1. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A, Fusco A, Magnani A, Marini MA, Di Daniele N, Gatti S, Lauro R.
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [Abstract] [Full Text] [Related]

  • 2. Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism.
    Leite V, Devesa J, Valdés L, Sobrinho LG.
    Horm Metab Res; 1990 Sep; 22(9):499-503. PubMed ID: 2147915
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O, Papadias K, Konidaris S, Bakalianou K, Salakos N, Vrachnis N, Creatsas G.
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [Abstract] [Full Text] [Related]

  • 4. [Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration].
    Urbancsek J, Rabe T, Gör U, Schulte B, Grunwald K, Papp Z, Runnebaum B.
    Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):617-25. PubMed ID: 1834511
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Aug; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 6. Finasteride treatment for one year in 35 hirsute patients.
    Bayram F, Müderris II, Sahin Y, Keleştimur F.
    Exp Clin Endocrinol Diabetes; 1999 Aug; 107(3):195-7. PubMed ID: 10376445
    [Abstract] [Full Text] [Related]

  • 7. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC, Ertunc D, Evruke C, Dilek S.
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F.
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 11. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 12. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE, Anania C, Malinak R.
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [Abstract] [Full Text] [Related]

  • 13. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 15. [Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].
    Wikiera B, Wasikowa R.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 May; 12(1):13-8. PubMed ID: 16704856
    [Abstract] [Full Text] [Related]

  • 16. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
    Müderris II, Bayram F, Ozçelik B, Güven M.
    Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL, Monroe SE, Jaffe RB.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [Abstract] [Full Text] [Related]

  • 18. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A.
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [Abstract] [Full Text] [Related]

  • 19. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A, Simberg N, Stenman UH, Ylikorkala O.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [Abstract] [Full Text] [Related]

  • 20. [Androgens and other hormones in buserelin therapy].
    Fuchs U, Zwirner M.
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):140-2. PubMed ID: 1904040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.